Absorption Systems is upgrading its AAALAC-accredited and GLP facility in San Diego, CA, expanding in vivo testing capabilities for drugs and medical devices. The expansion includes the construction of a dedicated ocular testing lab with a Heidelberg Spectralis optical coherence tomography (OCT) unit, an instrument that produces detailed digital images of the retina, enabling more precise monitoring of the efficacy and toxicity of drugs and medical devices.

The company’s preclinical ocular test portfolio includes in vivo ocular pharmacokinetics, efficacy, and safety in multiple species, as well as in vitro ocular permeability and metabolism.

Patrick Dentinger, president and chief executive officer of Absorption Systems, said, “For Absorption Systems, being a market leader in whatever endeavor we pursue is a cornerstone of our business philosophy. This requires scientific expertise, state-of-the-art equipment and facilities, and access to emerging technologies. These factors, combined with Absorption Systems’ customer-centric approach, make our commitment to being a top-tier ocular service provider a reality in 2012.”